Vir Biotechnology, Inc. (VIR)
Vir Biotechnology Market Cap : 1.421B for Nov. 20, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2026 | 1.421B |
| November 19, 2026 | 1.503B |
| November 18, 2026 | 1.550B |
| November 17, 2026 | 1.567B |
| November 16, 2026 | 1.623B |
| November 13, 2026 | 1.687B |
| November 12, 2026 | 2.053B |
| November 11, 2026 | 2.224B |
| November 10, 2026 | 2.228B |
| November 09, 2026 | 2.312B |
| November 06, 2026 | 2.069B |
| November 05, 2026 | 1.867B |
| November 04, 2026 | 1.994B |
| November 03, 2026 | 1.901B |
| November 02, 2026 | 1.861B |
| October 30, 2026 | 1.912B |
| October 29, 2026 | 1.988B |
| October 28, 2026 | 2.018B |
| October 27, 2026 | 1.957B |
| October 26, 2026 | 1.868B |
| October 23, 2026 | 1.788B |
| October 22, 2026 | 1.765B |
| October 21, 2026 | 1.788B |
| October 20, 2026 | 1.817B |
| October 19, 2026 | 1.727B |
| Date | Value |
|---|---|
| October 16, 2026 | 1.685B |
| October 15, 2026 | 1.771B |
| October 14, 2026 | 1.761B |
| October 13, 2026 | 1.795B |
| October 12, 2026 | 1.912B |
| October 09, 2026 | 1.979B |
| October 08, 2026 | 1.881B |
| October 07, 2026 | 1.949B |
| October 06, 2026 | 1.963B |
| October 05, 2026 | 1.993B |
| October 02, 2026 | 1.890B |
| October 01, 2026 | 1.910B |
| September 30, 2026 | 1.891B |
| September 29, 2026 | 1.802B |
| September 28, 2026 | 1.778B |
| September 25, 2026 | 1.804B |
| September 24, 2026 | 1.814B |
| September 23, 2026 | 1.876B |
| September 22, 2026 | 1.946B |
| September 21, 2026 | 1.841B |
| September 18, 2026 | 1.793B |
| September 17, 2026 | 1.848B |
| September 16, 2026 | 1.780B |
| September 15, 2026 | 1.766B |
| September 14, 2026 | 1.821B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Moderna, Inc. | 78.78B |
| Vaxcyte, Inc. | 8.270B |
| Oncolytics Biotech, Inc. | 46.29M |
| Sangamo Therapeutics, Inc. | 43.91M |
| Sarepta Therapeutics, Inc. | 1.429B |
Market Cap Related Metrics
| PS Ratio | 4.328 |
| Price to Book Value | 1.586 |
| Price | 8.39 |
| Earnings Yield | -14.97% |